Review ArticleReview Articles
Open Access
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L.C. Hygino da Cruz, I. Rodriguez, R.C. Domingues, E.L. Gasparetto and A.G. Sorensen
American Journal of Neuroradiology December 2011, 32 (11) 1978-1985; DOI: https://doi.org/10.3174/ajnr.A2397
L.C. Hygino da Cruz Jr
aFrom the Department of Radiology (L.C.H.C.), Clinics IRM, Clinica de Diagnóstico por Imagen and Multi-Imagem, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
I. Rodriguez
bImagen Médica Avanzada (I.R.), Madrid, Spain
R.C. Domingues
cClinics Clinica de Diagnóstico por Imagen and Multi-Imagem (R.C.D.), Rio de Janeiro, Brazil
E.L. Gasparetto
dDepartment of Radiology (E.L.G.), Clinics Clinica de Diagnóstico por Imagen and Multi-Imagem, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
A.G. Sorensen
eDepartment of Radiology, (A.G.S.), Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.

References
- 1.↵
- Stupp R,
- Mason WP,
- van den Bent MJ,
- et al
- 2.↵
- Macdonald DR,
- Cascino T,
- Schold SJ,
- et al
- 3.↵
- Wen PY,
- Macdonald DR,
- Reardon DA,
- et al
- 4.↵
- Sorensen AG,
- Batchelor TT,
- Wen PY,
- et al
- 5.↵
- 6.↵
- Kumar AJ,
- Leeds NE,
- Fuller GN,
- et al
- 7.↵
- Ulmer S,
- Braga TA,
- Barker FG 2nd.,
- et al
- 8.↵
- de Wit MC,
- de Bruin HG,
- Eijkenboom W,
- et al
- 9.↵
- Brandsma D,
- Stalpers L,
- Taal W,
- et al
- 10.↵
- Taal W,
- Brandsma D,
- de Bruin HG,
- et al
- 11.↵
- Brandes AA,
- Franceschi E,
- Tosoni A,
- et al
- 12.↵
- Brandes AA,
- Tosoni A,
- Franceschi E,
- et al
- 13.↵
- Chamberlain MC
- 14.↵
- Chaski C,
- Neyns B,
- Michotte A,
- et al
- 15.↵
- Mangla R,
- Singh G,
- Ziegelitz D,
- et al
- 16.↵
- Sanghera P,
- Perry J,
- Sahgal A,
- et al
- 17.↵
- Clarke JL,
- Abrey LE,
- Karimi S,
- et al
- 18.↵
- 19.↵
- Jefferies S,
- Burton K,
- Jones P,
- et al
- 20.↵
- Brandes AA,
- Tosoni A,
- Spagnolli F,
- et al
- 21.↵
- Tsien C,
- Galbán CJ,
- Chenevert TL,
- et al
- 22.↵
- Gahramanov S,
- Raslan AM,
- Muldoon LL,
- et al
- 23.↵
- Clarke JL,
- Chang S
- 24.↵
- Sundgren PC,
- Fan X,
- Weybright P,
- et al
- 25.↵
- Sundgren PC
- 26.↵
- Ricci PE,
- Karis JP,
- Heiserman JE,
- et al.
- 27.↵
- 28.↵
- Batchelor TT,
- Sorensen AG,
- di Tomaso E,
- et al
- 29.↵
- Pope WB,
- Lai A,
- Nghiemphu P,
- et al
- 30.↵
- Norden AD,
- Young GS,
- Setayesh K,
- et al
- 31.↵
- Jain RK,
- Duda DG,
- Willett CG,
- et al
- 32.↵
- Gerstner ER,
- Chen PJ,
- Wen PY,
- et al
- 33.↵
- Pope WB,
- Kim HJ,
- Huo J,
- et al
- 34.↵
- 35.↵
- Sorensen AG,
- Batchelor TT,
- Zhang WT,
- et al
In this issue
Advertisement
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L.C. Hygino da Cruz, I. Rodriguez, R.C. Domingues, E.L. Gasparetto, A.G. Sorensen
American Journal of Neuroradiology Dec 2011, 32 (11) 1978-1985; DOI: 10.3174/ajnr.A2397
Jump to section
Related Articles
- No related articles found.
Cited By...
- Spatiotemporal Heterogeneity in Multiparametric Physiologic MRI Is Associated with Patient Outcomes in IDH-Wildtype Glioblastoma
- 18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
- A comprehensive proteomic SWATH-MS workflow for profiling blood extracellular vesicles: a new avenue for glioma tumour surveillance
- Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance
- Synthesizing a Contrast-Enhancement Map in Patients with High-Grade Gliomas Based on a Postcontrast MR Imaging Quantification Only
- Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches
- Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas
- Detection of immune responses after immunotherapy in glioblastoma using PET and MRI
- Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
- Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma
- Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas
- Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma
- Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
- Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
- Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma
- Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma
- Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy
- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis
- In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma
- Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab
- Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression
- Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy
- Multimodal Magnetic Resonance Imaging and 18F-L-Dihydroxyphenylalanine Positron Emission Tomography in Early Characterization of Pseudoresponse and Nonenhancing Tumor Progression in a Pediatric Patient With Malignant Transformation of Ganglioglioma Treated With Bevacizumab
- Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
- Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement